🇺🇸 FDA
Pipeline program

Oral Ifetroban

CPI-IFE-004

Phase 2 small_molecule active

Quick answer

Oral Ifetroban for Scleroderma, Diffuse is a Phase 2 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Scleroderma, Diffuse
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials